BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment PKX Q4 2025 Earnings Massive EPS Miss Highlights Severe Operational Headwinds NWN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds FUL Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Rises 25 DOX Q1 2026 Earnings Narrow EPS Miss Weighs on Sentiment as Revenue Picture Remains Unclear